Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.
about
High-throughput sequencing reveals an altered T cell repertoire in X-linked agammaglobulinemia.Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunityRituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice.
P2860
Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@en
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@nl
type
label
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@en
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@nl
prefLabel
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@en
Rituximab-induced interleukin- ...... ement in rheumatoid arthritis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Rituximab-induced interleukin- ...... vement in rheumatoid arthritis
@en
P2093
Carme Geli
César Díaz-López
César Díaz-Torné
Elisabet Cantó
Héctor Corominas
Josep M de Llobet
M Angels Ortiz de Juana
P2860
P304
P356
10.1111/IMM.12212
P577
2014-07-01T00:00:00Z